(Total Views: 269)
Posted On: 09/21/2018 1:39:00 PM
Post# of 72446
It was well written. And seeing both Leo and Dr. B comment was a plus. Doesn't really matter to me that it wasn't anything we didn't already know but did put everything in a nutshell as well as invigorating confidence that they are still alive and well.
They could break some better news next week.
Getting this taken care of soon would be a good thing.
Prurisol for Psoriasis
· A top priority of the Company remains to unblind and analyze topline results from its completed Phase 2b trial (see NCT02949388) of oral Prurisol for the treatment of Moderate-to-Severe Chronic Plaque Psoriasis. Enrolling up to 199 patients, and based upon the protocol for 12 weeks of Prurisol treatment and an additional patient follow-up for 4 weeks, the study builds on a prior successfully completed Phase 2 trial of oral Prurisol in Mild-to-Moderate Chronic Plaque Psoriasis. A novel Psoriasis drug, particularly one that is oral, safe and effective, which could expand patient and physician choices for treatment, likely would command significant market value.
They could break some better news next week.
Getting this taken care of soon would be a good thing.
Prurisol for Psoriasis
· A top priority of the Company remains to unblind and analyze topline results from its completed Phase 2b trial (see NCT02949388) of oral Prurisol for the treatment of Moderate-to-Severe Chronic Plaque Psoriasis. Enrolling up to 199 patients, and based upon the protocol for 12 weeks of Prurisol treatment and an additional patient follow-up for 4 weeks, the study builds on a prior successfully completed Phase 2 trial of oral Prurisol in Mild-to-Moderate Chronic Plaque Psoriasis. A novel Psoriasis drug, particularly one that is oral, safe and effective, which could expand patient and physician choices for treatment, likely would command significant market value.
(2)
(0)
